Vaccine Development

Moderna Clinical Trials Market Impact Novavax mRNA Technology Funding Market Reactions AstraZeneca Moderna Inc. Corporate Governance Collaboration Agreements Research and Development Research Funding Contracts Manufacturing COVID-19 Vaccine Investment Decisions Covid-19 Vaccines Seattle-based Cancer Vaccine Pfizer Corporate Deals Corporate Communication Market Response Pricing Strategies Market Competition Market Performance COVID-19 Vaccines Manufacturers Regulatory Affairs Valneva SE Valneva Manufacturing Agreements Company Acquisitions Technology Transfer Public Health Response Acquisitions Clinical Research Research and Trials

12 ARTICLES

3mo ago

Moderna Starts Phase 1 Trial in Canada for Bundibugyo Ebola Vaccine

The move launches rapid safety testing for a strain with no approved vaccine; favorable early results would allow larger trials and shape potential supply for low‑income countries.

7 ARTICLES

7mo ago

Pfizer and BioNTech Halt U.S. COVID Vaccine Trial for 50–64-Year-Olds Over Slow Enrollment

5 ARTICLES

10mo ago

CEPI Puts Up to $54.3 Million Behind Moderna’s H5 mRNA Bird Flu Vaccine for Phase 3

11 ARTICLES

last yr.

FDA Suspends Valneva’s Ixchiq Chikungunya Vaccine Over Safety Reports

4 ARTICLES

last yr.

Moderna’s mRNA-1010 Flu Vaccine Outperforms Standard Shot and Advances Toward Approval

6 ARTICLES

last yr.

FDA Expands Moderna RSV Vaccine to Adults 18–59 at Risk

10 ARTICLES

last yr.

FDA Approves Moderna’s mNEXSPIKE for Seniors and High-Risk Adults as CDC Drops Recommendations for Healthy Children and Pregnant Women

30 ARTICLES

last yr.

HHS Withdraws $766 Million From Moderna’s Bird Flu Vaccine Program

4 ARTICLES

last yr.

Moderna Withdraws Flu-COVID Vaccine Application After FDA Requests More Data

16 ARTICLES

last yr.

FDA Grants Limited Approval to Novavax’s COVID-19 Vaccine